ANRO
Alto Neuroscience, Inc.
27.20$
-1.2%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | – | – | – | 100.0% | – | – | – | – | – | – | – | |
| – | 24.7% | – | – | – | 43.1% | – | – | – | – | – | – | – | |
| – | -24.7% | – | – | – | -43.1% | – | – | – | – | – | – | – | |
| – | 2,592.2% | – | – | – | 2,741.1% | – | – | – | – | – | – | – | |
| – | 570.4% | – | – | – | 1,572.8% | – | – | – | – | – | – | – | |
| – | 3,137.9% | – | – | – | 4,270.8% | – | – | – | – | – | – | – | |
| – | -3,162.6% | – | – | – | -4,314.0% | – | – | – | – | – | – | – | |
| – | 95.7% | – | – | – | 84.5% | – | – | – | – | – | – | – | |
| – | -3,015.3% | – | – | – | -3,858.1% | – | – | – | – | – | – | – | |
| – | -97.6% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -3,015.3% | – | – | – | -3,858.1% | – | – | – | – | – | – | – | |
| – | -2,894.9% | – | – | – | -3,730.5% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.